News Focus
News Focus
Followers 2
Posts 660
Boards Moderated 0
Alias Born 10/30/2004

Re: cmini123 post# 57

Friday, 07/21/2006 4:25:49 AM

Friday, July 21, 2006 4:25:49 AM

Post# of 2446
Re SRDX sentiment. cmini, I agree with some of what you said, for example that SRDX should invest much more in internal R&D, but I also disagree with much of what you said and in particular believe you miscalculate the value of SRDX's IP and industry branding in the near term. Sorry, I don't have time to address all the points you raise, but rather raise my own: have you taken a look to see how very much SRDX is in demand? From a partnership supply and demand perspective, things are looking very good for SRDX.

Re InnoRx technology value: I am more optimistic. Posurdex may be ahead of Ivation from a regulatory perspective, but it is hardly formidable (drug elution lasts about 4 weeks vs 1-2 years, yet the surgical implant lasts 6 months and is not removeable), and last I heard insertion was not an office procedure (pars plana incision followed by insertion through a 19 gauge Grieshaber cannula). SRDX will be late to the party? Is there anything competetive in clinical trials?

The obstacle to discovery is the illusion of knowledge.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRDX News